Clinical trials: Rhino-conjunctivitis
Hypersensitivity, Asthma
Quality of Life and Health Economic Measurements in Allergic Patients Treated With Immunotherapy
Grass pollen and house dust mites (HDM) are the most common allergens causing allergic rhino-conjunctivitis (RC) and/or asthma (A). Subcutaneous allergen specific immunotherapy (SCIT) reduces symptoms and use of medication.
- Conditions
- Hypersensitivity, Asthma, Rhino-Conjunctivitis, Quality of Life
- Trial name
- SABAL (NCT01486498)
- Volunteers
- 571 people, healthy volunteers welcome
- Sponsor
- Aalborg University
Allergic Rhino-Conjunctivitis, Urticaria
To Compare and Evaluate the Oral Bioavailability of Bilastine 20 mg Orally Dispersible Tablet With That of Bilaxten (Bilastine) 20 mg Orally Dispersible Tablet in Healthy, Adult, Human Subjects Under Fasting Conditions
An open label, balanced, randomized single-dose, two-treatment, two sequence, four-period, Full Replicate, crossover oral bioequivalence study in healthy, adult, human subjects under fasting condition.
- Trial name
- NCT07042828
- Testing
- Bilastine oral dispersible tablets, Bilaxten oral dispersible tablets
- Where
- India
- Volunteers
- 42 people, healthy volunteers welcome
- Sponsor
- Humanis Saglık Anonim Sirketi
Hypersensitivity, Immediate
Norwegian Birch Rust Allergy Study
This study investigates whether spores from birch rust fungi (Melampsoridium Betulinum = MB) may be the eliciting allergen in patients with seasonal airway allergy during autumn in North Norway.
- Trial name
- Nor-BRA (NCT05661812)
- Testing
- Quationnaires and symptom registration, PNIF and spirometry, SPT, spesific IgE, pBAT and NPT
- Where
- Norway
- Volunteers
- 287 people, healthy volunteers welcome
- Sponsor
- University Hospital of North Norway
Hypersensitivity
DBPC-Dose-finding-trial of Vitamin D3 for SCIT in Birch Pollen Allergic Patients.
Low Vitamin D3 (VD3) levels have been reported to be associated with the risk of allergic diseases like asthma. VD3 has been demonstrated in vitro, ex vivo and in animal models to program the immune system towards…
- Trial name
- BM4SIT (NCT02686827)
- Testing
- Paricalcitol
- Where
- Netherlands
- Volunteers
- 44 people, healthy volunteers welcome
- Sponsor
- Laurian Jongejan